Incision Device Articles & Analysis
9 news found
Sonata is brilliant in concept; it reduces symptoms without any incisions at all,” said John Thoppil, MD, FACOG and President of TAOG. ...
” The Sonata technology platform integrates the first and only commercial intrauterine ultrasound system with a proprietary advanced radiofrequency ablation device, providing an incision-free, uterus-preserving, transcervical treatment for symptomatic uterine fibroids. ...
The Sonata technology platform integrates the first and only commercial intrauterine ultrasound system with a proprietary advanced radiofrequency ablation device, providing an incision-free, uterus-preserving, transcervical treatment for symptomatic uterine fibroids. ...
This expert consensus led to a new recommended treatment algorithm for each fibroid type: “When we began evaluating transcervical radiofrequency fibroid ablation (TRFA) using Sonata, we quickly learned that this technique, a completely incision free procedure, would be applicable for a wide range of fibroid types and patients,” said Prof. ...
Redwood City, CA, June 11, 2021 – Gynesonics®, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced today Blue Cross Blue Shield of Florida (Florida Blue) has released a coverage policy for its Sonata® Procedure.1 The addition of the Florida Blue policy allows another 5 million covered lives in ...
The Sonata technology platform integrates the first and only commercial intrauterine ultrasound system with a proprietary advanced radiofrequency ablation device, providing an incision-free, uterus-preserving, transcervical treatment for symptomatic uterine fibroids. ...
This pilot study tested Aatru Medical’s NPSIMSTM technology (Negative Pressure Surgical Incision Management System), a patented, low-cost-ofmanufacture, non-electrical device that uses solid state oxygen management technology (OxMT) to create and sustain a mean negative pressure of -81.1 mmHg in test negative pressure wound therapy (NPWT) dressings. ...
"The application submission is the culmination of much work across a range of expertise over the past few years, and we look forward to the time when the product can benefit patients with surgical incisions," said Armstrong. Aatru has strategically targeted the Negative Pressure Wound Therapy (NPWT) for surgical incision market as there are 250MM annual ...
“We’ll be working with our collaborators to look at tympanostomy tube (ear tube) surgery and the outcomes of that and how we can improve ear tube surgeries in the US, which is one of the biggest markets for us,” she said. AventaMed’s device is called the Solo Tympanostomy Tube Device (Solo TTD), which simplifies the surgeries. ...